On May 18, Bank of America analyst Travis Steed lowered the firm’s price target on Embecta Corp. (NASDAQ:EMBC) to $3 from $11 ...

Embecta closed its acquisition of Owen Mumford Holdings on Friday, shifting its focus from diabetes products to broader ...

Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced transaction to acquire Owen Mumford Holdings ...

President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific ...

The transaction supports Embecta’s plan to diversify by supplying drug delivery solutions to pharmaceutical partners.

Embecta's most recent quarterly report didn't give investors much to be exicited about.

Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported second quarter ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 6:00 PM EDTCompany ParticipantsDevdatt Kurdikar - President, CEO ...

Becton, Dickinson and Co.’s board of directors approved the company’s diabetes spinoff, and set a date of April 1 for the move. The announcement of Embecta Corp.’s approval came Feb. 1, along with a ...

When Embecta spun out from BD just over a year ago, the newly formed diabetes giant already carried breakthrough designation for an insulin patch pump that would specifically target the Type 2 ...

The January ribbon cutting at embecta‘s new global headquarters in Parsippany was the latest step for one of the world’s largest pure-play diabetes management companies. “It was a really important ...

In this article, we will discuss 7 Best Rated Penny Stocks to Buy According to Wall Street Analysts. Penny stocks remain one of the most controversial corners of the market — capable of producing ...